Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Operating Leases (2022 - 2025)

Lucid Diagnostics' Operating Leases history spans 4 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 31.42% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, down 31.42%, while the annual FY2025 figure was $1.8 million, 31.42% down from the prior year.
  • Operating Leases reached $1.8 million in Q4 2025 per LUCD's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.9 million in Q3 2024 to a low of $464000.0 in Q3 2023.
  • Average Operating Leases over 4 years is $1.7 million, with a median of $1.8 million recorded in 2023.
  • Peak YoY movement for Operating Leases: crashed 76.83% in 2023, then skyrocketed 517.67% in 2024.
  • A 4-year view of Operating Leases shows it stood at $1.0 million in 2022, then increased by 25.84% to $1.3 million in 2023, then skyrocketed by 103.37% to $2.7 million in 2024, then plummeted by 31.42% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Operating Leases are $1.8 million (Q4 2025), $2.0 million (Q3 2025), and $1.4 million (Q2 2025).